Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
7.24M
-
Shares change
-
-838K
-
Total reported value, excl. options
-
$63M
-
Value change
-
-$7.61M
-
Put/Call ratio
-
0.5
-
Number of buys
-
37
-
Number of sells
-
-26
-
Price
-
$8.71
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q4 2021
92 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q4 2021.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.24M shares
of 53.4M outstanding shares and own 13.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.24M shares), VANGUARD GROUP INC (1.48M shares), STATE STREET CORP (539K shares), GEODE CAPITAL MANAGEMENT, LLC (506K shares), Janney Montgomery Scott LLC (286K shares), NORTHERN TRUST CORP (267K shares), Retirement Planning Co of New England, Inc. (211K shares), GOLDMAN SACHS GROUP INC (191K shares), Nuveen Asset Management, LLC (100K shares), and Kovack Advisors, Inc. (88.3K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.